The morning opened up on a high note for this dually-listed company as it announced U.S. Food and Drug Administration (FDA) approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501 )....

To read the full story on AllPennyStocks.com, click here.

Appili Therapeutics (PK) (USOTC:APLIF)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Appili Therapeutics (PK) Charts.
Appili Therapeutics (PK) (USOTC:APLIF)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Appili Therapeutics (PK) Charts.